Simplify Logo

Full-Time

Equity Administrator

Posted on 5/31/2024

PROCEPT BioRobotics

PROCEPT BioRobotics

501-1,000 employees

Develops robotic solutions for BPH treatment

Biotechnology
Healthcare

Compensation Overview

$86k - $119kMonthly

+

Junior

San Jose, CA, USA

Requires onsite presence in San Jose, California for hybrid work setup.

Category
Accounts & Payroll
Legal
Legal & Compliance
Requirements
  • 2+ years experience in equity administration
  • Bachelor’s degree
  • Interest in global equity programs
  • Strong interpersonal skills
  • Proficient in word processing and spreadsheets
  • Self-starter with exceptional organizational skills
Responsibilities
  • Administer company's stock plans
  • Prepare and maintain transaction details
  • File SEC forms 3, 4, and 5
  • Coordinate trading plans and annual reviews
  • Respond to questions from employees and vendors
  • Partner with various departments
  • Maintain equity data records
  • Prepare tax reporting documentation
  • Provide support to attorneys
  • Adhere to company policies

PROCEPT BioRobotics develops robotic solutions specifically for treating benign prostatic hyperplasia (BPH), a condition that affects many older men by causing prostate enlargement and urinary issues. Their main product, the AquaBeam Robotic System, utilizes Aquablation therapy, which combines real-time imaging, robotics, and waterjet technology to precisely remove prostate tissue in a minimally invasive manner. This system is designed for urologists and healthcare facilities, allowing for improved patient outcomes and more efficient surgical procedures. Unlike competitors, PROCEPT BioRobotics focuses on providing predictable results and reducing complications, which has led to their technology being recognized in clinical guidelines. The company's goal is to enhance the quality of life for patients suffering from BPH through advanced surgical solutions.

Company Stage

IPO

Total Funding

$637.7M

Headquarters

Redwood City, California

Founded

2009

Growth & Insights
Headcount

6 month growth

10%

1 year growth

37%

2 year growth

112%
Simplify Jobs

Simplify's Take

What believers are saying

  • Long-term data demonstrating the sustained benefits of Aquablation therapy enhances the company's reputation and supports its market position.
  • Significant investments, including $118 million in equity financing, provide the financial resources needed for global expansion and innovation.
  • FDA approval for investigating Aquablation therapy for prostate cancer opens new market opportunities and potential revenue streams.

What critics are saying

  • Ongoing investigations by law firms into possible securities fraud could damage the company's reputation and investor confidence.
  • The medical device market is highly competitive, and maintaining technological leadership requires continuous innovation and substantial investment.

What makes PROCEPT BioRobotics unique

  • PROCEPT BioRobotics specializes in Aquablation therapy, a unique minimally invasive treatment for BPH that combines real-time imaging, robotics, and waterjet technology, setting it apart from traditional surgical methods.
  • The company's focus on urology and the treatment of BPH allows it to develop highly specialized and effective solutions, unlike competitors with broader medical device portfolios.
  • The inclusion of PROCEPT's technology in clinical practice guidelines underscores its credibility and effectiveness, distinguishing it from less established competitors.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE